Multimodal imaging-therapeutic nanoprobe TiO(2)@RhdGd was prepared and successfully used for in vitro and in vivo cell tracking as well as for killing of cancer cells in vitro. TiO(2) nanoparticles were used as a core for phosphonic acid modified functionalities, responsible for contrast in MRI and optical imaging. The probe shows high (1)H relaxivity and relaxivity density values. Presence of fluorescent dye allows for visualization by means of fluorescence microscopy. The applicability of the probe was studied, using mesenchymal stem cells, cancer HeLa cells, and T-lymphocytes. The probe did not exhibit toxicity in any of these systems. Labeled cells were successfully visualized in vitro by means of fluorescence microscopy and MRI. Furthermore, it was shown that the probe TiO(2)@RhdGd can be changed into a cancer cell killer upon UV light irradiation. The above stated results represent a valuable proof of a principle showing applicability of the probe design for diagnosis and therapy.

Department of Inorganic Chemistry Faculty of Science Charles University Prague Hlavova 2030 128 40 Prague 2 Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12028261

003      

CZ-PrNML

005      

20130201091357.0

007      

ta

008      

120817e20110705xxu f 000 0#eng||

009      

AR

024    7_

$a 10.1021/jm200449y $2 doi

035    __

$a (PubMed)21662977

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Řehoř, Ivan $u Department of Inorganic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030, 128 40 Prague 2, Czech Republic.

245    10

$a Phosphonate-titanium dioxide assemblies: platform for multimodal diagnostic-therapeutic nanoprobes / $c I. Řehoř, V. Vilímová, P. Jendelová, V. Kubíček, D. Jirák, V. Herynek, M. Kapcalová, J. Kotek, J. Černý, P. Hermann, I. Lukeš,

520    9_

$a Multimodal imaging-therapeutic nanoprobe TiO(2)@RhdGd was prepared and successfully used for in vitro and in vivo cell tracking as well as for killing of cancer cells in vitro. TiO(2) nanoparticles were used as a core for phosphonic acid modified functionalities, responsible for contrast in MRI and optical imaging. The probe shows high (1)H relaxivity and relaxivity density values. Presence of fluorescent dye allows for visualization by means of fluorescence microscopy. The applicability of the probe was studied, using mesenchymal stem cells, cancer HeLa cells, and T-lymphocytes. The probe did not exhibit toxicity in any of these systems. Labeled cells were successfully visualized in vitro by means of fluorescence microscopy and MRI. Furthermore, it was shown that the probe TiO(2)@RhdGd can be changed into a cancer cell killer upon UV light irradiation. The above stated results represent a valuable proof of a principle showing applicability of the probe design for diagnosis and therapy.

650    _2

$a afinitní značky $x chemická syntéza $x chemie $x farmakologie $7 D000345

650    _2

$a zvířata $7 D000818

650    _2

$a antitumorózní látky $x chemická syntéza $x chemie $x farmakologie $7 D000970

650    _2

$a viabilita buněk $x účinky léků $7 D002470

650    _2

$a komplexní sloučeniny $x chemická syntéza $x chemie $x farmakologie $7 D056831

650    _2

$a léky antitumorózní - screeningové testy $7 D004354

650    _2

$a fluorescenční barviva $x chemická syntéza $x chemie $x farmakologie $7 D005456

650    _2

$a gadolinium $7 D005682

650    _2

$a HeLa buňky $7 D006367

650    _2

$a lidé $7 D006801

650    _2

$a magnetická rezonanční tomografie $7 D008279

650    _2

$a mezenchymální kmenové buňky $x metabolismus $7 D059630

650    _2

$a myši $7 D051379

650    _2

$a fluorescenční mikroskopie $7 D008856

650    _2

$a nanočástice $7 D053758

650    _2

$a kyseliny fosforité $x chemická syntéza $x chemie $x farmakologie $7 D010757

650    _2

$a vztahy mezi strukturou a aktivitou $7 D013329

650    _2

$a T-lymfocyty $x metabolismus $7 D013601

650    _2

$a titan $x chemie $x farmakologie $7 D014025

650    _2

$a ultrafialové záření $7 D014466

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Vilímová, Vanda

700    1_

$a Jendelová, Pavla

700    1_

$a Kubíček, Vojtěch

700    1_

$a Jirák, Daniel

700    1_

$a Herynek, Vít

700    1_

$a Kapcalová, Miroslava

700    1_

$a Kotek, Jan

700    1_

$a Černý, Jan

700    1_

$a Hermann, Petr

700    1_

$a Lukeš, Ivan

773    0_

$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 54, č. 14 (20110705), s. 5185-94

856    41

$u https://pubmed.ncbi.nlm.nih.gov/21662977 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m

990    __

$a 20120817 $b ABA008

991    __

$a 20130201091525 $b ABA008

999    __

$a ok $b bmc $g 950303 $s 785607

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2011 $b 54 $c 14 $d 5185-94 $e 20110705 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049

LZP    __

$a Pubmed-20120817/11/04